Feeding Intolerance in Preterm Clinical Trial
Official title:
Influence of Bovine Lactoferrin on Feeding Intolerance and Intestinal Permeability in Preterm Neonates: a Randomized Controlled Trial
Verified date | January 2021 |
Source | Mansoura University Children Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Preterm infants are at increased risk of developing feeding intolerance due to functional immaturity of their gastrointestinal tract and may lead to discontinuation of enterak feeding. Lactoferrin promotes the growth of probiotic bacteria, stimulates differntiation and proliferation of enterocytes and expression of intestinal digestive enzymes , lead to improvement of feeding intolerance. So we hypothesized that supplementation of bovine lactoferrin would be benificial on feeding intolerance and decrease intestinal permeability in preterm infants with feeding intolerance.
Status | Active, not recruiting |
Enrollment | 60 |
Est. completion date | June 2022 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 26 Weeks to 34 Weeks |
Eligibility | Inclusion Criteria: - preterm infants delivered at gestational age 26 to 34 weeks admitted to NICU OF mansoura university children hospital Diagnosed as feeding intolerance defined as gastric volume residual of more than 50% of the previous feeding volume, gastric regurgitation, abdominal distention and or emesis Receive premature cow's protein based formula enteral feeding Exclusion Criteria: Major congenital malformations Anatomical gastrointestinal anomalies Birth asphyxia Presence of NEC Neonate receiving Expressed breast milk Infant with history of cow's milk allergy - |
Country | Name | City | State |
---|---|---|---|
Egypt | Mansoura University Children Hospital | Mansoura |
Lead Sponsor | Collaborator |
---|---|
Mansoura University Children Hospital |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duration required by the infant to achieve full enteral feeding | Full enteral feed reached when infant tolerated 150ml/kg/day | 4 weeks or till discharge from NICU, whichever came first | |
Primary | Serum zonulin concentrations at day 7 and 4 weeks after enrollment or discharge | serum zonulin is an indicator for intestinal permeability | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Number of episodes of gastric residual more than 50% of the previous feed | Number of episodes of gastric residual more than 50% of the previous feed | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Weight gain | weight gain during admission | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Late onset sepsis | by sighs and Lab. investigation of sepsis | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Total numbers of days of antimicrobial administration | Total numbers of days of antimicrobial administration | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Duration of parenteral nutrition | during NICU stay | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Necrotizing enterocolitis | Bell stage 2 or 3 | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Duration of hospital stay | Duration of hospital stay | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Iron status after 4 week of enrollment | serum iron , serum ferritin, TIBC | 4 weeks or till discharge from NICU, whichever came first | |
Secondary | Side effect from the drug | vomiting , rash | 4 weeks or till discharge from NICU, whichever came first |